Cargando…
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
Autores principales: | Innao, Vanessa, Urso, Salvatore, Insalaco, Monica, Borraccino, Albino, Consoli, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723754/ https://www.ncbi.nlm.nih.gov/pubmed/35033862 http://dx.doi.org/10.1016/j.thromres.2021.12.029 |
Ejemplares similares
-
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
por: Giuffrida, Gaetano, et al.
Publicado: (2021) -
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Immune thrombocytopenic purpura: case report
Publicado: (2021) -
Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female
por: Jasaraj, Ranjit B, et al.
Publicado: (2021) -
Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review
por: Dan, Chitramalya, et al.
Publicado: (2023)